` CSHLPress.com - Chromatin deregulation Cancer


CSHL Press News

New book on Chromatin Deregulation in Cancer from CSHL Press

06/07/2017

The human genome is packaged into chromatin, which is composed of numerous proteins that help control gene expression, DNA replication and repair, and genome stability. In recent years, it has become clear that the deregulation of chromatin structure plays an important role in numerous cancers.

Written and edited by experts in the field, Chromatin Deregulation in Cancer from Cold Spring Harbor Perspectives in Medicine examines the chromatin components that are commonly mutated, what is understood about the mechanisms that lead to hematological malignancies and solid tumors, and prospects for the therapeutic modulation of chromatin. The contributors describe how histone proteins, histone-modifying enzymes, chromatin remodelers, transcriptional regulatory complexes, enhancer-associated factors, and signaling proteins are dysregulated in cancer pathogenesis. In addition, the roles of DNA methylation and noncoding RNAs are covered.

The authors also discuss small molecules and other drugs that are currently under development or already used to treat cancer (e.g., HDAC inhibitors and DNA hypomethylating agents). This book is therefore essential reading for all cancer biologists, cell and molecular biologists, and pharmacologists interested in understanding cancer therapies.


IMAGE: The image depicts six broad categories of chromatin regulatory mechanisms, which are all known to be altered via mutations in the pathogenesis of human cancer.


CREDIT:
Figure adapted by Meredith Cassuto, Cold Spring Harbor Laboratory, from the cover of Epigenetics, 2nd ed., 2015, with permission from CSHL Press



Return to CSHL Press News index